Ascendis Pharma’s strong Q3 2025 revenue and innovative therapies drive growth and profitability. Click here to read an ...
Despite the importance of GoF modifications, they have sometimes faced misplaced concerns or opposition that could lead to their being overregulated or even banned.
Amazon S3 on MSN
Hollywood Stars Who Are Open About Their Steroid Use…
Hollywood has long been fascinated with physical transformation, and some stars have been candid about the methods behind ...
Donga ST announced on December 2 that it received the Minister of Health and Welfare Award for "Innovative Pharmaceutical ...
The latest update is out from COSCIENS Biopharma ( ($TSE:CSCI) ). On December 1, 2025, COSCIENS Biopharma Inc. announced an exclusive distribution ...
COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life sciences company focused on ...
Ascendis Pharma (ASND) has delivered some interesting performance numbers lately, with the stock climbing over 9% in the past 3 months and more than 53% year to date. This recent momentum has caught ...
Efficacy and Safety of Aromatase Inhibitor Combined with Growth Hormone in Korean Boys with Idiopathic Short Stature: A ...
The report thoroughly investigates the present and future scenarios of the global Protein therapeutics market. It highlights key trends and emerging opportunities while addressing challenges faced ...
Cantor Fitzgerald analysts have connected with Danish biotech Ascendis Pharma’s on the three-month Prescription Drug User Fee ...
From its base in the Southern Taiwan Science Park, the company has launched several drugs in the world's largest pharmaceutical markets, including the US and Canada, and aims to introduce one new drug ...
In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results